What Are the Serious Side Effects of GLP-1?

Last reviewed: May 15, 2026 Last updated: May 15, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

GLP-1 receptor agonist medications have transformed weight loss treatment for millions of people, with clinical evidence showing significant and sustained results. However, like all medications, GLP-1 drugs carry potential risks that patients should understand before starting therapy. PlexusDx helps individuals make informed decisions by providing transparent information about both common and serious side effects, ensuring safe and personalized treatment.

How GLP-1 Medications Work in Your Body

GLP-1 (glucagon-like peptide-1) receptor agonists mimic a natural hormone that regulates appetite, blood sugar, and digestive processes. Compounded semaglutide and tirzepatide are the two most widely used medications in this class, with semaglutide featured prominently in the STEP trials and tirzepatide in the SURMOUNT trials. These medications slow stomach emptying, increase feelings of fullness, and reduce hunger signals sent to the brain.

The medications work by binding to GLP-1 receptors located throughout your digestive system and brain. When you understand how these drugs function at a cellular level, you're better equipped to recognize when side effects develop. PlexusDx uses genetic testing to map your individual peptide pathways, revealing how your body may respond to GLP-1 therapy differently than others.

Common GLP-1 Side Effects vs. Serious Complications

Most patients experience temporary nausea, vomiting, diarrhea, or constipation during the first weeks of GLP-1 therapy. These mild to moderate effects typically resolve as your body adjusts to the medication, and dosing schedules are designed to minimize discomfort. However, serious side effects require immediate medical evaluation and may necessitate stopping treatment altogether.

The distinction between common and serious side effects matters because serious complications can cause permanent organ damage or life-threatening emergencies. Knowing which symptoms warrant a call to your doctor versus an emergency room visit is critical for safe GLP-1 use. PlexusDx provides clear guidance on monitoring protocols and warning signs specific to your treatment plan.

Acute Pancreatitis: When GLP-1 Triggers Pancreatic Inflammation

Acute pancreatitis is inflammation of the pancreas that can develop suddenly in patients taking GLP-1 medications, though the overall incidence remains relatively low. Symptoms include severe upper abdominal pain that radiates to the back, persistent vomiting, rapid heartbeat, and yellowing of the skin or eyes. Risk increases in individuals with personal or family history of pancreatitis, high triglyceride levels, or gallstone disease.

The STEP and SURMOUNT clinical trials identified pancreatitis as a reportable adverse event, though cases were uncommon in the study populations. If you experience sudden, severe abdominal pain while on semaglutide or tirzepatide, seek emergency care immediately—pancreatitis requires hospitalization and discontinuation of GLP-1 therapy. Your PlexusDx provider will assess your baseline pancreatic health before starting any GLP-1 medication.

Gallbladder Disease and Cholecystitis Risk

GLP-1 medications slow the rate at which food moves through your stomach and intestines, which reduces the frequency of gallbladder contractions. Over time, reduced gallbladder movement can lead to bile stasis and gallstone formation, a condition called cholecystitis. Studies show that rapid weight loss from any cause—including GLP-1 therapy—increases gallstone development, particularly in patients with genetic predisposition.

Warning signs of gallbladder problems include sharp pain in the upper right abdomen, pain between the shoulder blades, right shoulder pain, and nausea after eating fatty foods. The Precision Peptide Genetic Test offered by PlexusDx examines genetic markers related to metabolic pathways that influence gallbladder health and lipid metabolism. If gallbladder disease develops, your doctor may recommend ultrasound imaging and possible temporary discontinuation of GLP-1 therapy.

Severe Hypoglycemia When Combined With Other Diabetes Medications

Hypoglycemia (dangerously low blood sugar) becomes a serious concern when GLP-1 medications are used alongside insulin or sulfonylureas, which are medications that increase insulin secretion. The combination can cause blood sugar to drop below 54 mg/dL, leading to confusion, loss of consciousness, seizures, or permanent brain damage if untreated. This risk is greater in individuals with long-standing diabetes or those taking multiple blood sugar-lowering agents.

Symptoms of severe hypoglycemia include sudden shakiness, profuse sweating, intense anxiety, rapid or irregular heartbeat, and difficulty speaking. Patients on combined therapy must monitor blood sugar frequently and have glucagon emergency kits available at all times. PlexusDx reviews all concurrent medications during your initial consultation to identify hypoglycemia risk factors and recommend appropriate monitoring schedules.

Kidney Function Changes and Dehydration-Related Complications

GLP-1 medications can reduce kidney function indirectly through volume depletion caused by persistent vomiting and diarrhea, particularly during dose escalation phases. Patients with existing chronic kidney disease face higher risk of acute kidney injury if dehydration develops. Signs of kidney problems include dark or decreased urine output, swelling in legs or feet, fatigue, and difficulty concentrating.

The STEP and SURMOUNT trials monitored kidney function markers in participants, and current safety protocols require baseline kidney assessments before initiating GLP-1 therapy. PlexusDx obtains your kidney function tests (estimated glomerular filtration rate, or eGFR) prior to prescribing semaglutide or tirzepatide. If your kidney function declines during treatment, your dosing schedule may be adjusted or therapy paused to prevent progression to acute kidney failure.

Frequently Asked Questions About What Are the Serious Side Effects of GLP-1?

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.